Your browser doesn't support javascript.
loading
Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
Huebecker, Mylene; Moloney, Elizabeth B; van der Spoel, Aarnoud C; Priestman, David A; Isacson, Ole; Hallett, Penelope J; Platt, Frances M.
Affiliation
  • Huebecker M; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
  • Moloney EB; Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA.
  • van der Spoel AC; Departments of Pediatrics and Biochemistry & Molecular Biology, Atlantic Research Centre, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
  • Priestman DA; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
  • Isacson O; Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA. isacson@hms.harvard.edu.
  • Hallett PJ; Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA. phallett@mclean.harvard.edu.
  • Platt FM; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK. frances.platt@pharm.ox.ac.uk.
Mol Neurodegener ; 15(1): 6, 2020 Jan 15.
Article in En | MEDLINE | ID: mdl-31937358
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Neurodegener Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Neurodegener Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido